International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 158 | Views: 240

Research Paper | Biomedical Sciences | India | Volume 8 Issue 8, August 2019


Matrix Metalloproteinase-3 Associated with Severity of Rheumatoid Arthritis: A Meta Analysis

Sucheta Dandekar | Aparna Sagare | Anjali Rajyadhyaksha


Abstract: Our study examined the relationship between the levels of matrix metalloproteinases [MMP]-3 and the pathogenesis of Rheumatoid Arthritis [RA] & among severity of the disease. We employed rigorous inclusion and exclusion criteria in various bibliographic databases to extract published studies relevant to this investigation. The Revman manager version 5.3 & winpepi version 11.65 software was used for the statistical analysis. A total of 329 studies were initially searched, and 6 studies with 652 RA patients and 658 healthy controls were included in this meta-analysis. Results are represented in terms of Odds ratios [ORs] and 95 % confidence intervals [CIs] to estimate the association between MMP-3 and RA. There was significant association between MMP-3 and RA. Significance between study heterogeneity existed between mild and severe RA. The meta-analysis results suggested that the levels of MMP-3 were higher in patients with RA than those in the control group. Subgroup analysis according to severity showed that the levels of MMP-3 were higher in severe RA than in mild RA. We systematically investigated the association between MMP-3 and RA susceptibility; however, the results show a correlation among the disease severity & these raised level of MMP-3 associated with the pathogenesis of RA.


Keywords: Rheumatoid arthritis, Matrix metalloproteinase, Meta-analysis


Edition: Volume 8 Issue 8, August 2019,


Pages: 223 - 228


How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link


Verification Code will appear in 2 Seconds ... Wait

Top